Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $482,486 | -67.2% | 98,870 | -3.0% | 0.08% | -66.5% |
| Q3 2022 | $1,470,000 | -6.8% | 101,970 | -2.1% | 0.22% | 0.0% |
| Q2 2022 | $1,577,000 | +24.4% | 104,200 | -2.4% | 0.22% | +63.5% |
| Q1 2022 | $1,268,000 | -65.4% | 106,770 | -52.8% | 0.14% | -62.6% |
| Q4 2021 | $3,666,000 | -71.6% | 226,180 | -50.0% | 0.37% | -68.8% |
| Q3 2021 | $12,903,000 | -34.6% | 452,110 | -22.5% | 1.17% | -34.1% |
| Q2 2021 | $19,723,000 | +28.4% | 583,508 | +14.8% | 1.78% | +24.0% |
| Q1 2021 | $15,364,000 | +41.4% | 508,083 | +131.6% | 1.44% | +36.5% |
| Q4 2020 | $10,863,000 | – | 219,419 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |